Abstract

Becton Dickinson (BD) is a $2.5 billion medical technology company. Our primary product lines are disposable medical devices such as syringes, needles and scalpels. The other half of the business is diagnostic instruments and systems, ranging from one‐step pregnancy tests to large instrument systems. Fifty‐five percent of our sales are in the U.S., although our international segment is growing much faster than our domestic operations.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call